Mirae Asset Global Investments’s Ocular Therapeutix OCUL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $57.1K | Buy |
6,154
+893
| +17% | +$8.29K | ﹤0.01% | 1236 |
|
|
2025
Q1 | $39.9K | Buy |
5,261
+22
| +0.4% | +$167 | ﹤0.01% | 1277 |
|
|
2024
Q4 | $44.2K | Sell |
5,239
-400
| -7% | -$3.38K | ﹤0.01% | 1282 |
|
|
2024
Q3 | $48.9K | Buy |
5,639
+1,015
| +22% | +$8.81K | ﹤0.01% | 1308 |
|
|
2024
Q2 | $31.3K | Sell |
4,624
-48,832
| -91% | -$330K | ﹤0.01% | 1325 |
|
|
2024
Q1 | $284K | Buy |
+53,456
| New | +$284K | ﹤0.01% | 2125 |
|
|
2023
Q4 | – | Sell |
-52,049
| Closed | -$163K | – | 2578 |
|
|
2023
Q3 | $163K | Buy |
52,049
+112
| +0.2% | +$352 | ﹤0.01% | 2357 |
|
|
2023
Q2 | $268K | Sell |
51,937
-147
| -0.3% | -$759 | ﹤0.01% | 2230 |
|
|
2023
Q1 | $274K | Buy |
+52,084
| New | +$274K | ﹤0.01% | 2204 |
|
|
2022
Q4 | – | Sell |
-33,415
| Closed | -$139K | – | 2572 |
|
|
2022
Q3 | $139K | Buy |
33,415
+9,823
| +42% | +$40.9K | ﹤0.01% | 2439 |
|
|
2022
Q2 | $95K | Buy |
+23,592
| New | +$95K | ﹤0.01% | 2313 |
|